abstract |
The present invention relates to a method of reducing testosterone levels by reducing luteinizing hormone (LH) in male subjects or irrespective of LH levels, treating, inhibiting, reducing the incidence, reducing or inhibiting advanced prostate cancer, and progressive prostate A palliative treatment of cancer. |